Supplementary MaterialsCEOR-11-159-192235. of cost per QALY gained. Robustness of results was confirmed by sensitivity analyses and alternative scenario analyses. Results Secukinumab achieved highest QALYs (13.1) at lowest expected lifetime cost (279,872) vs other comparators in biologic-na?ve AS patients in the base case analysis, it dominated other biologics as a result. Golimumab had another highest QALYs… Continue reading Supplementary MaterialsCEOR-11-159-192235. of cost per QALY gained. Robustness of results was
Tag: exhaustion
Objectives The usage of biologic agents has revolutionized the management of
Objectives The usage of biologic agents has revolutionized the management of rheumatoid arthritis (RA) in the past 2 decades. 1, 2009 and December 31, 2011, for a biologic that was approved for treatment of RA. The patients were buy 5633-20-5 followed for 12 months after enrollment. The clinical characteristics of the patients enrolled in this… Continue reading Objectives The usage of biologic agents has revolutionized the management of